Kasai, K.; Igarashi, N.; Tada, Y.; Kani, K.; Takano, S.; Yanagibashi, T.; Usui-Kawanishi, F.; Fujisaka, S.; Watanabe, S.; Ichimura-Shimizu, M.;
et al. Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice. Int. J. Mol. Sci. 2023, 24, 4050.
https://doi.org/10.3390/ijms24044050
AMA Style
Kasai K, Igarashi N, Tada Y, Kani K, Takano S, Yanagibashi T, Usui-Kawanishi F, Fujisaka S, Watanabe S, Ichimura-Shimizu M,
et al. Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice. International Journal of Molecular Sciences. 2023; 24(4):4050.
https://doi.org/10.3390/ijms24044050
Chicago/Turabian Style
Kasai, Kaichi, Naoya Igarashi, Yuki Tada, Koudai Kani, Shun Takano, Tsutomu Yanagibashi, Fumitake Usui-Kawanishi, Shiho Fujisaka, Shiro Watanabe, Mayuko Ichimura-Shimizu,
and et al. 2023. "Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice" International Journal of Molecular Sciences 24, no. 4: 4050.
https://doi.org/10.3390/ijms24044050
APA Style
Kasai, K., Igarashi, N., Tada, Y., Kani, K., Takano, S., Yanagibashi, T., Usui-Kawanishi, F., Fujisaka, S., Watanabe, S., Ichimura-Shimizu, M., Takatsu, K., Tobe, K., Tsuneyama, K., Furusawa, Y., & Nagai, Y.
(2023). Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice. International Journal of Molecular Sciences, 24(4), 4050.
https://doi.org/10.3390/ijms24044050
